RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Adaptilens

Adaptilens

The Adaptilens A-IOL recaptures the eye’s ability to accommodate by responding to its natural signal to focus without spectacle dependence.

Latest funding

$18M Series A ·

Source: startupintros.com

Latest round on record: Series A, May 2026, amount undisclosed.

Total raised: $20M across 2 sourced rounds

All 3 rounds ↓
Website: adaptilens.com.
LinkedIn: adaptilens.
Category: Health and bio.
Stage: Series A.
Total raised: $20M in 2 sourced rounds.
Last round: May 11, 2026 · 189 days ago.
On Recent Funding since: Nov 6, 2026.

Signals

Website registeredApr 26, 2018 (8 years old)
TIMELINE · MONEY RAISED

Adaptilens | 2206 days on the record

Raised $20M in 2 sourced rounds
$5.0M$10M$15M$20MNOVSEPJULMAYMARJAN 2025NOVSEP$20M$2M Seed · Nov 1, 2020$2M SEED · NOV '20$18M Series A · Apr 1, 2024$18M A · APR '24Series A · May 11, 2026A · MAY '26

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series Aundisclosed—fundraisingfox.com
Series A$18M—startupintros.com
Seed$2M—startupintros.com

Timeline

  1. Website created

Founders and team

Companies like Adaptilens

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/adaptilens (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy